HCA vs UHS
HCA Healthcare, Inc. and Universal Health Services Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | HCA | UHS |
|---|---|---|
| Revenue | $75.6B | $17.4B |
| Net income | $6.8B | $1.5B |
| Gross margin | · | · |
| Net margin | 10.3% | 8.7% |
| Return on equity | · | 21.4% |
| Diluted EPS | $28.33 | $23.10 |
| Dividend / share | $2.88 | $0.80 |
| Payout ratio | 10.0% | 3.4% |
| Free cash flow | $7.7B | $849.2M |
| Equity | $-6.0B | $7.3B |
| Net debt / equity | · | 0.63× |
| Current ratio | 0.97× | 1.05× |
| Revenue CAGR 5y | 8.0% | 8.5% |
| Profit CAGR 5y | 12.6% | 9.5% |
HCA bills 4.4× the revenue of UHS, and keeps more of each dollar of revenue as profit (10.3% against 8.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | HCA | UHS |
|---|---|---|
| FY2025 | $75.6B | $17.4B |
| FY2024 | $70.6B | $15.8B |
| FY2023 | $65.0B | $14.3B |
| FY2022 | $60.2B | $13.4B |
| FY2021 | $58.8B | $12.6B |
| FY2020 | $51.5B | $11.6B |
| FY2019 | $51.3B | $11.4B |
| FY2018 | $46.7B | $10.8B |
| FY2017 | $43.6B | $10.4B |
| FY2016 | $41.5B | $9.8B |
Bottom line
| Fiscal year | HCA | UHS |
|---|---|---|
| FY2025 | $6.8B | $1.5B |
| FY2024 | $5.8B | $1.1B |
| FY2023 | $5.2B | $717.8M |
| FY2022 | $5.6B | $675.6M |
| FY2021 | $7.0B | $991.6M |
| FY2020 | $3.8B | $944.0M |
| FY2019 | $3.5B | $814.9M |
| FY2018 | $3.8B | $779.7M |
| FY2017 | $2.2B | $752.3M |
| FY2016 | $2.9B | $702.4M |
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$58,235,171,000 | HCA |
| FY2024 | +$54,775,065,000 | HCA |
| FY2023 | +$50,686,024,000 | HCA |
| FY2022 | +$46,833,630,000 | HCA |
| FY2021 | +$46,109,883,000 | HCA |
| FY2020 | +$39,974,103,000 | HCA |
| FY2019 | +$39,957,741,000 | HCA |
| FY2018 | +$35,904,722,000 | HCA |
| FY2017 | +$33,204,135,000 | HCA |
| FY2016 | +$31,723,790,000 | HCA |
| FY2014 | +$28,712,912,000 | HCA |
| FY2013 | +$26,814,127,000 | HCA |
| FY2012 | +$26,051,600,000 | HCA |
| FY2011 | +$22,921,778,000 | HCA |
| FY2010 | +$23,134,853,000 | HCA |
| FY2009 | +$21,573,621,000 | HCA |
HCA has reported the higher revenue in every one of these 16 fiscal years. The gap has widened since the earliest year compared.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +1.6 pp | HCA |
| FY2024 | +2.1 pp | HCA |
| FY2023 | +4.3 pp | HCA |
| FY2022 | +6.4 pp | HCA |
| FY2021 | +5.3 pp | HCA |
| FY2020 | +0.3 pp | HCA |
| FY2019 | +0.8 pp | HCA |
| FY2018 | +2.0 pp | HCA |
| FY2017 | −1.1 pp | UHS |
| FY2016 | +0.6 pp | HCA |
| FY2014 | −0.9 pp | UHS |
| FY2013 | −1.7 pp | UHS |
| FY2012 | −0.9 pp | UHS |
| FY2011 | +2.9 pp | HCA |
| FY2010 | −0.0 pp | UHS |
| FY2009 | −0.7 pp | UHS |
The higher net margin has changed hands between HCA and UHS over this period.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
HCA's net margin has been more volatile than UHS's over the 16 comparable fiscal years — 2.2 percentage points of standard deviation against 1.1.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between HCA and UHS over these 16 fiscal years — HCA led in 10 and UHS in 6.
16 of 18 comparable fiscal years — a year missing data on either side is not counted.